| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873025 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
Calcium hydroxyapatite injection after MI progressively improves global left ventricular function, borderzone function, and mitral regurgitation. Using novel biomaterials to augment infarct material properties is a viable alternative in the current management of heart failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeremy R. MD, Norihiro MD, Walter R.T. PhD, Manabu MD, Chikashi MD, Jason A. PhD, Francis G. MD, PhD, Joseph H. MD, James J. PhD, Robert C. MD,